| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | Oct 2, 2025 | VYNE Therapeutics Inc. | CHIEF SCIENTIFIC OFFICER | Sell | 47.5 | -2,453 | -2.04% | ✗ | $821.8 |
| Jun 30, 2025 | Jul 2, 2025 | VYNE Therapeutics Inc. | CHIEF SCIENTIFIC OFFICER | Sell | 47.5 | -2,453 | -2.00% | ✗ | $4K |
| Mar 31, 2025 | Apr 2, 2025 | VYNE Therapeutics Inc. | CHIEF SCIENTIFIC OFFICER | Sell | 47.5 | -6,044 | -4.70% | ✗ | $9.5K |
| Dec 31, 2024 | Jan 2, 2025 | VYNE Therapeutics Inc. | CHIEF SCIENTIFIC OFFICER | Sell | 46.3 | -4,857 | -3.64% | ✗ | $16.3K |
| Sep 30, 2024 | Oct 2, 2024 | VYNE Therapeutics Inc. | CHIEF SCIENTIFIC OFFICER | Sell | 52.5 | -109 | -0.08% | ✗ | $204.9 |
| Jul 1, 2024 | Jul 3, 2024 | VYNE Therapeutics Inc. | CHIEF SCIENTIFIC OFFICER | Sell | 52.5 | -138 | -0.10% | ✗ | $265 |
| Apr 1, 2024 | Apr 3, 2024 | VYNE Therapeutics Inc. | CHIEF SCIENTIFIC OFFICER | Sell | 52.5 | -157 | -0.12% | ✗ | $483.6 |
| Jan 1, 2024 | Jan 3, 2024 | VYNE Therapeutics Inc. | Chief Scientific Officer | Sell | 90.0 | +62,343 | 87.13% | ✗ | $358 |
| Oct 2, 2023 | Oct 4, 2023 | VYNE Therapeutics Inc. | Chief Scientific Officer | Sell | 47.5 | -1,184 | -11.56% | ✗ | $4.5K |
| Jun 30, 2023 | Jul 5, 2023 | VYNE Therapeutics Inc. | Chief Scientific Officer | Sell | 47.5 | -151 | -1.45% | ✗ | $619.1 |
| Mar 31, 2023 | Apr 4, 2023 | VYNE Therapeutics Inc. | Chief Scientific Officer | Sell | 47.5 | -480 | -4.42% | ✗ | $1.5K |
| Dec 31, 2022 | Jan 4, 2023 | VYNE Therapeutics Inc. | Chief Scientific Officer | Sell | 50.0 | -1,720 | -0.77% | ✗ | $258 |
| Sep 30, 2022 | Oct 4, 2022 | VYNE Therapeutics Inc. | Chief Scientific Officer | Sell | 50.0 | -1,719 | -0.77% | ✗ | $383.3 |
| Jun 30, 2022 | Jul 5, 2022 | VYNE Therapeutics Inc. | Chief Scientific Officer | Sell | 50.0 | -1,719 | -0.76% | ✗ | $668.7 |
| Mar 31, 2022 | Apr 4, 2022 | VYNE Therapeutics Inc. | Chief Scientific Officer | Sell | 47.5 | -3,469 | -1.52% | ✗ | $2.3K |
| Dec 31, 2021 | Jan 4, 2022 | VYNE Therapeutics Inc. | Chief Scientific Officer | Sell | 50.0 | -1,250 | -0.81% | ✗ | $1.3K |
| Sep 30, 2021 | Oct 1, 2021 | VYNE Therapeutics Inc. | Chief Scientific Officer | Sell | 50.0 | -1,480 | -0.95% | ✗ | $2.1K |
| Jun 30, 2021 | Jul 2, 2021 | VYNE Therapeutics Inc. | Chief Scientific Officer | Sell | 46.3 | -3,083 | -3.12% | ✗ | $10.8K |
| Mar 31, 2021 | Apr 2, 2021 | VYNE Therapeutics Inc. | Chief Scientific Officer | Sell | 46.3 | -1,945 | -1.93% | ✗ | $13.3K |
| Dec 31, 2020 | Jan 5, 2021 | VYNE Therapeutics Inc. | Chief Scientific Officer | Sell | 50.0 | -2,378 | -0.82% | ✗ | $3.8K |
| Sep 30, 2020 | Oct 2, 2020 | VYNE Therapeutics Inc. | Chief Scientific Officer | Sell | 50.0 | -2,378 | -0.82% | ✗ | $3.9K |
| Jun 30, 2020 | Jul 2, 2020 | VYNE Therapeutics Inc. | Chief Scientific Officer | Sell | 50.0 | -2,378 | -0.81% | ✗ | $4.1K |
| Apr 3, 2020 | Apr 7, 2020 | VYNE Therapeutics Inc. | Chief Scientific Officer | Sell | 90.0 | +121,449 | 204.28% | ✗ | $5.3K |
| Mar 31, 2020 | Apr 2, 2020 | VYNE Therapeutics Inc. | Chief Scientific Officer | Sell | 47.5 | -1,940 | -3.16% | ✗ | $5.2K |